Article

Silicone hydrogel contact lens for astigmatism available nationwide

A silicone hydrogel contact lens (Avaria Toric, CooperVision) for patients with astigmatism is now available nationwide.

Pleasanton, CA-A silicone hydrogel contact lens (Avaria Toric, CooperVision) for patients with astigmatism is now available nationwide. The lens was launched in June, but demand was so high that it was restricted to a few thousand customers who had fittings scheduled, according to the company.

The toric lens is designed to provide improved visual performance in a broad range of astigmatic eyes, regardless of cylinder power or axis, through the positioning of the lens ballast and the smooth, junctionless surface of the lens. In addition, the lens features a consistent horizontal thickness across the power range to improve lens stability and reduce rotation, and a wide ballast band that completely encircles the optic zone to optimize lens-lid interaction for both orientation and comfort. It includes a naturally wettable lens and technology that retains water, minimizing dehydration and eliminating the need for wetting agents, coatings, or additives.

The contact lens is manufactured from enfilcon A material. Water content is 46%, Dk is 100, and Dk/t is 91. The lens features sphere powers from plano to –6.00 D; a base curve of 8.5 mm; a diameter of 14.5 mm; cylinders of –0.75, –1.25, and –1.75 D; and an axis from 10° to 180° in 10° steps. An expanded SKU range will be launched in the future.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
Sheng Lim, MD, FRCOphth, discusses the CONCEPT study, which compared standalone cataract surgery to cataract surgery with ECP, at the 2025 ASCRS Annual Meeting.
(Image credit: Ophthalmology Times) ASCRS 2025: Steven J. Dell, MD, reports 24-month outcomes for shape-changing IOL
© 2025 MJH Life Sciences

All rights reserved.